Clinical trial in COVID-19 patients tests anti-inflammatory drug developed 25 years ago at Scripps Research
On Apr. 29, 2020, an anti-inflammatory drug developed at Scripps Research 25 years ago tested as a way…
Electron microscopy technique revealed how a key human antibody disarms many strains of HIV
On Apr. 29, 2020, Scripps researchers announced they had developed a method for examining the machinery of HIV…
Emory University helped lead research on drug to treat COVID-19 patients
On Apr. 29, 2020, Emory University played a leading role in the government-sponsored clinical trial of the COVID-19…
Hologic to introduce second high-throughput molecular assay for novel Coronavirus (SARS-CoV-2)
On Apr. 29, 2020, Hologic announced that it planned to launch a new Aptimaﾮ molecular assay to detect…
University of Nebraska Medical Center remdesivir clinical trial show accelerated recovery from advanced COVID-19
On Apr. 29, 2020, hospitalized patients with advanced COVID-19 and lung involvement who received remdesivir recovered faster than…
Catalent signs agreement with Johnson & Johnson to be US manufacturing partner for lead COVID-19 vaccine candidate
On Apr. 29, 2020, Catalent announced a collaboration with the Janssen Pharmaceutical Companies of Johnson & Johnson, whereby…
Chimerix announced initiation of phase 2/3 study of DSTAT in acute lung injury for patients with severe COVID-19
On Apr. 29, 2020, Chimerix announced initiation of a Phase 2/3 study of dociparstat sodium (DSTAT) in COVID-19…
OPKO Health’s BioReference Laboratories partnership with New York State initiated testing for COVID-19 antibodies
On Apr. 29, 2020, BioReference Laboratories, an OPKO Health company, announced that it will continue to prioritize COVID-19…
Clinical trial began to see if convalescent plasma can treat COVID-19
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine and NYU Langone…
Clinical trial of drug hydroxychloroquine for treatment of COVID-19 began at Montefiore and Einstein
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine announced that they…
Windtree announced first patient enrolled in AEROSURF bridging study for treatment of Respiratory Distress Syndrome
On Apr. 29, 2020, Windtree Therapeutics announced it has enrolled the first patient into its AEROSURF phase 2b…
Texas A&M researchers lead testing of tuberculosis vaccine to fight COVID-19
On Apr. 29, 2020, a team of Texas A&M University researchers asked hundreds of frontline medical workers to…
Entos Pharmaceuticals partnered with EpiVax to develop a pan-Coronavirus DNA vaccine
On Apr. 28, 2020, Entos Pharmaceuticals announced a collaboration with EpiVax. This partnership combined the Entos Fusogenix DNA…
Dutch consortium began production of millions of medical face masks for healthcare professionals in the Netherlands
On Apr. 28, 2020, the Dutch consortium of AFPRO Filters, Royal Auping, and Royal DSM began large-scale production…
Illumina’s donation to Africa Centre for Disease Control expanded capability for sequencing-based COVID-19 surveillance
On Apr. 28, 2020, Illumina announced that the African Union Commission, on behalf of the Africa Center for…
Secarna Pharma entered into cooperation with Guangzhou’s Sun Yat-sen University to develop treatment for SARS-CoV-2 viral infections
On Apr. 28, 2020, Secarna Pharmaceuticals announced the company has entered into a cooperation with the First Affiliated…
Sarepta Therapeutics announced research agreement with U.S. DoD to evaluate multiple constructs from proprietary RNA platform as treatments for COVID-19
On Apr. 28, 2020, Sarepta Therapeutics announced the Company and the USAMRIID, the Department of Defense’s lead laboratory…
Quest Diagnostics launched consumer-Initiated COVID-19 antibody test through QuestDirectﾙ
On Apr. 28, 2020, Quest Diagnostics announced that individuals can purchase COVID-19 antibody testing for themselves online, without…
Chimerix received FDA clearance for rolling submission of New Drug Application for brincidofovir as medical countermeasure for smallpox
On Apr. 28, 2020, Chimerix announced it had received clearance from the FDA for a rolling submission of…
Albert Einstein College of Medicine invented compound tested in COVID-19 clinical trial
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine announced that a…
INOVIO completed enrollment in phase 1 U.S. trial of INO-4800 for COVID-19 DNA vaccine
On Apr. 28, 2020, INOVIO announced that its Phase 1 U.S. clinical trial for COVID-19 DNA vaccine INO-4800…
INOVIO and GeneOne reported positive phase 1/2a clinical data with DNA vaccine INO-4700 for MERS Coronavirus
On Apr. 28, 2020, INOVIO and GeneOne Life Science announced interim data through week 16 from a Phase…
UW-Madison researchers created hybrids of six yeast species to combine useful traits
On Apr. 28, 2020, researchers at the Great Lakes Bioenergy Research Center at the University of Wisconsin-Madison have…
Meridian Bioscience simplified COVID-19 sample prep and eliminated dependence on reagents in short supply
On Apr. 27, 2020, Meridian Bioscience announced the launch of a novel enzyme master mix (Inhibitor Tolerant 1-step…
Aegis Sciences doubled capacity for Coronavirus disease 2019 (COVID-19) testing
On Apr. 27, 2020, Aegis Sciences announced expanded capacity to incrementally ramp up to 7,000 tests per day…
iBio estimated 500 Million Dose Capacity for COVID-19 Vaccine from its FastPharming Facility
On Apr. 27, 2020, iBio announced it has joined the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL),…
Ichor announced its TriGrid Delivery System is being utilized for delivery in non-human primates of a COVID-19 DNA vaccine being developed by Naval Medical Research Center
On Apr. 27, 2020, Ichor announced that its TriGrid Delivery System is being utilized for delivery in non-human…
Diffusion Pharma announced pre-IND submission to FDA of design for TSC trials to treat Acute Respiratory Distress Syndrome in COVID-19
On Apr. 27, 2020, Diffusion Pharmaceuticals announced the pre-IND submission to the FDA of a planned clinical program…
Merck and Institute for Systems Biology collaborate to define molecular mechanisms of SARS-CoV-2 infection and identify potential prognostic biomarkers
On Apr. 27, 2020, Merck and the Institute for Systems Biology announced a new research collaboration to investigate…
CTI Biopharma announced initiation of phase 3 PRE-VENT study evaluating Pacritinib in hospitalized patients with severe COVID-19
On Apr. 27, 2020, CTI BioPharma announced initiation of PRE-VENT, a Phase 3 study evaluating pacritinib in hospitalized…